**Conor Mulvanerton’s Journey: Battling Cancer and Reclaiming Life**
:max_bytes(150000):strip_icc():format(jpeg)/Barista-Cancer-052926-tout-28673a1c66f74de8ae0b40f59118bd5c.jpg)
In the summer of 2024, Conor Mulvanerton, a 26-year-old New Jersey native, began experiencing unusual health issues that would alter the course of his life. What started as mere exhaustion and relentless night sweats, which he attributed to the demands of his job at Starbucks, soon escalated into a significant health crisis. Mulvanerton found himself relying heavily on caffeine to power through early shifts, but no amount of espresso could shake off the fatigue that had become his constant companion.
Reflecting on those times, Mulvanerton admits, “On some days, I would consume up to eight espresso shots and still manage to sleep after my shifts.” This persistent tiredness, combined with frequent night sweats, was dismissed by both him and his family, who attributed it to the stresses of youth, long hours, and a lack of sleep. However, by autumn, the warning signs had become too pronounced to ignore.

After graduating from college, Mulvanerton was eager to break into the advertising industry. His mornings were spent at Starbucks, and his afternoons were filled with applications for various positions. Nevertheless, the exhaustion began to weigh heavily on him. “I noticed the symptoms in spring 2024 when I had to wake up at 3:50 a.m. Despite all the caffeine, I still felt drained,” he explained.

In July 2024, Mulvanerton secured a temporary role in corporate advertising in New York City, and for a brief moment, he felt optimistic about his future. “It was my first proper job in advertising, and I was excited,” he remarked. Unfortunately, this excitement was short-lived as his health continued to deteriorate. Eventually, an ultrasound revealed significantly swollen lymph nodes, a condition he had not previously considered.
On November 14, 2024, the life-changing news came: he was diagnosed with stage II Hodgkin’s lymphoma, a cancer that impacts the immune system and lymphatic system. His oncologist tried to reassure him, suggesting that if one were to develop cancer, this was the most treatable type. At first, the chemotherapy seemed effective, but it soon became clear that his battle was far from over.
Despite undergoing twelve rounds of chemotherapy, subsequent tests revealed that the cancer had not been eradicated. “I received news from a PET scan that changed my life forever,” Mulvanerton shared, confronting the daunting reality of his situation. The emotional and physical toll of chemotherapy also began to affect his professional life. While his employer offered support, allowing him to work from home and adjust his hours, he ultimately had to turn down a full-time position due to his deteriorating health.
Seeking a fresh start, Mulvanerton transferred his care to Memorial Sloan Kettering in New York City, where he underwent an additional round of chemotherapy and, eventually, an autologous stem cell transplant in September 2025. Throughout this trying period, the unwavering support from friends and family proved invaluable. He recalls a particularly uplifting gesture—a collection of handwritten letters from loved ones that served as a source of strength as he prepared for his transplant.
Music also played a pivotal role in his recovery, with artists like Lorde and Tame Impala providing motivation during his most challenging days. The thought of attending concerts again became a beacon of hope, urging him to persevere through treatment. “The idea that once I achieve remission I could return to concerts kept me going,” he noted.
By December 2025, his first PET scan post-transplant revealed encouraging results—there were no signs of cancer in his body. This marked a significant turning point for Mulvanerton, who is now focused on rebuilding his health and strength. Embracing running as a newfound outlet and adopting healthier habits, he has shifted away from processed foods and alcohol, determined to champion his well-being.
Now, as he reflects on his journey from diagnosis to recovery, he acknowledges the rapid pace at which life has changed. “From the time of my diagnosis to now, I feel as though I blinked and the world had moved on,” he expressed. Despite facing another scan soon, he maintains a positive outlook on life. “My primary focus is simply to survive for as long as possible,” Mulvanerton concluded, embodying the resilience that has characterised his battle against cancer.
